Menopur

Menotropin, the active ingredient in Menopur, is a gonadotropin presented as an injection solution for subcutaneous use. It treats infertility related to anovulation and is employed in assisted reproductive technology to stimulate ovarian follicular development and estrogen production, supporting egg retrieval for in‑vitro fertilisation cycles.

GNH USA supplies Menopur as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring quality assurance, regulatory compliance, and reliable cold‑chain logistics for biologic products. The company adheres to stringent Good Distribution Practice standards and provides comprehensive documentation for regulatory submissions.

Menopur (menotropin) acts on the hypothalamic‑pituitary‑ovarian axis to promote follicular growth and ovulation in women undergoing fertility treatment.

- Infertility due to anovulation: stimulates follicular development to enable ovulation. - Assisted reproductive technology (ART): provides combined FSH and LH activity for controlled ovarian stimulation. - Controlled ovarian stimulation: enhances estrogen production and follicle maturation for egg retrieval.

Menopur may cause a range of adverse reactions, most of which are related to its hormonal activity and injection route.

Common Side Effects: - Injection site pain or erythema - Abdominal discomfort or bloating - Nausea or mild vomiting - Headache - Mild ovarian hyperstimulation - Fatigue

Serious or Rare Side Effects: - Severe ovarian hyperstimulation syndrome (OHSS) - Multiple pregnancy - Allergic reaction or anaphylaxis - Thromboembolic events - Ectopic pregnancy - Severe abdominal pain

When using Menopur, careful monitoring and patient selection are essential to minimise risks.

- Dose individualisation: adjust based on ovarian response and monitoring results. - Monitor for ovarian hyperstimulation: watch for rapid weight gain, abdominal distension, or shortness of breath. - Assess thyroid function: avoid use in uncontrolled thyroid disease. - Confirm negative pregnancy test before initiation. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Menopur can interact with other hormonal or systemic agents that affect ovarian response.

Major Interactions (Avoid): - GnRH antagonists: may reduce Menopur efficacy. - Oral contraceptives: suppress endogenous gonadotropins, interfering with stimulation. - High‑dose estrogen therapy: may alter ovarian response.

Moderate Interactions (Monitor Closely): - Thyroid hormone replacement: monitor thyroid status during treatment. - Glucocorticoids: may affect follicular development. - Anticoagulants: monitor bleeding risk if invasive procedures are performed.